MiniMax concurrent HK$16.04 billion placement of shares and convertible bonds
We advised MiniMax on its concurrent placement of new Class A shares and convertible bonds issuance
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Ascentage Pharma $200 million at-the-market offering
We advised the sales agents on the offering
GenFleet Therapeutics HK$471.8 million placement of new H shares
We advised GenFleet Therapeutics on the placement
Mizuho Financial Group $6.6 billion senior notes offering
We advised the joint bookrunners and joint lead managers on the offering
Xunce concurrent HK$784M placement of new H shares and CNY1.36B convertible bonds
We advised Xunce on its concurrent placement of new H shares and convertible bonds issuance
EACON HK$2.64 billion Hong Kong IPO
We advised EACON on its IPO and HKEX listing
Momenta HK$6.78 billion Hong Kong IPO
We advised Momenta on its IPO and HKEX listing
SMFG $3.25 billion senior notes offering
We advised SMFG on the offering
Anker Innovations Technology HK$5.33 billion Hong Kong IPO
We advised Anker Innovations Technology on its IPO and HKEX listing
State Bank JSC $100 million senior notes offering
We advised the placement agent on the high-yield private placement